You are here: Industry Insights > Russia

News List

Russia approves Sputnik V Covid-19 vaccine for senior citizens pharmaceutical-technology
December 29, 2020
The Russian government has approved its Covid-19 vaccine, Sputnik V, for use by individuals aged 60 years and above.
Russia to vaccinate armed forces against COVID-19 as new cases hit daily record expresspharma
November 30, 2020
Russia plans to vaccinate more than 400,000 military personnel against COVID-19, Defence Minister Sergei Shoigu said on Friday, as authorities reported a record 27,543 new coronavirus cases.
Sputnik V vaccine shows 92 per cent efficacy in ongoing phase III trials in Russia expresspharma
November 12, 2020
The confirmation is based on the first interim data from the double-blind, randomized, placebo-controlled Phase III clinical trials in Russia involving 40,000 volunteers.
RDIF and União Química file documents for registration of Sputnik V vaccine with regulator in Brazil worldpharmanews
November 02, 2020
The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), União Química Farmacêutica Nacional and the Government of the State of Paraná announce the pre-submission of preliminary documents to Brazil's National Health Surveillance Agency..
Russia applies for WHO emergency use tag for its COVID-19 vaccine expresspharma
October 28, 2020
The procedures would allow Sputnik V to be included in the list of medical products that meet leading quality.
First results of Russian coronavirus vaccine trial may include data from 5,000-10,000 people expresspharma
October 22, 2020
Preliminary results from the late-stage human trial of Russia’s main coronavirus vaccine candidate could include data from 5,000-10,000 participants, Denis Logunov, a director at the Gamaleya Institute that developed the vaccine, said on Monday.
Chumakov Center initiates Covid-19 vaccine candidate trials pharmaceutical-technology
October 22, 2020
Russia’s Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products has initiated clinical trials of its potential Covid-19 vaccine in St Petersburg.
Russia approves second COVID-19 vaccine expresspharma
October 16, 2020
The vaccine, developed by the Vector Institute in Siberia, completed early-stage human trials last month but the results have not been published yet and Phase III, trials have not yet begun.
Russia to supply Mexico with 32 million doses of Sputnik V europeanpharmaceuticalreview
September 24, 2020
The Russian Direct Investment Fund (RDIF) said the supply of the COVID-19 vaccine should enable 25 percent of the population to be vaccinated.
Russia’s Sputnik V COVID-19 vaccine safely elicits an antibody response, reports paper europeanpharmaceuticalreview
September 08, 2020
Preliminary data from Phase I/II trails evaluating the vaccine reveal 100 percent of participants had a humoral and cellular response, with no serious adverse events reported.

Previous page 1 2 3 4 Next page